The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Emigh James F since year 2005.
The trader's CIK number is 1107934.
At the time of this reporting, Emigh James F is the VP Corporate Development of Acura Pharmaceuticals, Inc .
(stock ticker symbol ACUR).
See this page for all insider trading activities at Acura Pharmaceuticals, Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-14||ACUR||Acura Pharmaceuticals, Inc||Buy||400,000||.10||40,000|
|2014-05-16||ACUR||Acura Pharmaceuticals, Inc||Buy||15,000||1.21||18,150|
|2014-01-24||ACUR||Acura Pharmaceuticals, Inc||Option Ex||6,225||1.30||8,092|
|2013-05-03||ACUR||Acura Pharmaceuticals, Inc||Option Ex||6,225||1.30||8,092|
|2012-01-27||ACUR||Acura Pharmaceuticals, Inc||Option Ex||6,225||1.30||8,092|
|2011-08-12||ACUR||Acura Pharmaceuticals, Inc||Buy||5,000||2.60||13,000|
|2011-01-21||ACUR||Acura Pharmaceuticals, Inc||Option Ex||6,225||1.30||8,092|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Emigh James F (VP Corporate Development of Acura Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.